Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
357
Employees357
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
357
Employees357

COLL Key Statistics

Market cap
1.04B
Market cap1.04B
Price-Earnings ratio
27.06
Price-Earnings ratio27.06
Dividend yield
Dividend yield
Average volume
301.69K
Average volume301.69K
High today
$32.95
High today$32.95
Low today
$31.91
Low today$31.91
Open price
$32.83
Open price$32.83
Volume
241.21K
Volume241.21K
52 Week high
$42.29
52 Week high$42.29
52 Week low
$23.23
52 Week low$23.23

COLL News

Simply Wall St 5d
Is Collegium Pharmaceutical, Inc.'s ROE Of 19% Impressive?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and...

Is Collegium Pharmaceutical, Inc.'s ROE Of 19% Impressive?

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.